Four Headlines Every Doctor Fears: Amazon GLP-1s, AI Replacing MDs, End of the Pen

About this episode

Dr. Adil Ahmed and Dr. Humayun Naqvi unpack four headlines rattling medicine: Amazon selling oral GLP-1 weight-loss drugs like orforglipron and oral Wegovy direct to consumers, a hospital CEO claiming AI could replace radiologists, AI chatbots from Legion Health refilling psychiatric meds in Utah, and Novo Nordisk partnering with OpenAI on drug discovery. They weigh conflicts of interest, the corporatization of healthcare, AI in insurance denials, and whether doctors get replaced by doctors who use AI well.

What we cover in this episode

1. Amazon selling GLP-1 weight loss drugs direct to consumers
2. orforglipron vs oral Wegovy oral GLP-1 pills
3. will AI replace radiologists
4. AI chatbots prescribing psychiatric medications
5. Novo Nordisk and OpenAI drug discovery partnership
6. conflicts of interest in retail healthcare
7. insurance companies using AI to deny claims
8. corporatization of medicine and physician shortage
9. AI safety risks in prescribing

Your hosts

Dr. Humayun NaqviPreventive Cardiologist · West Houston Heart Center

Dr. Adil AhmedOrthopedic Surgeon · Baylor College of Medicine

More episodes